BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12172574)

  • 1. Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India.
    Teni T; Pawar S; Sanghvi V; Saranath D
    Pathol Oncol Res; 2002; 8(2):109-14. PubMed ID: 12172574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis-associated proteins and the development of oral squamous cell carcinoma.
    Schoelch ML; Le QT; Silverman S; McMillan A; Dekker NP; Fu KK; Ziober BL; Regezi JA
    Oral Oncol; 1999 Jan; 35(1):77-85. PubMed ID: 10211314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis and expression of Bax and Bcl-2 in snuff- and non-snuff associated oral squamous cell carcinomas.
    Loro LL; Vintermyr OK; Ibrahim SO; Idris AM; Johannessen AC
    Anticancer Res; 2000; 20(5A):2855-60. PubMed ID: 11062693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity.
    Jordan RC; Catzavelos GC; Barrett AW; Speight PM
    Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):394-400. PubMed ID: 9039223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.
    Baltaziak M; Duraj E; Koda M; Wincewicz A; Musiatowicz M; Kanczuga-Koda L; Szymanska M; Lesniewicz T; Musiatowicz B
    Ann N Y Acad Sci; 2006 Dec; 1090():18-25. PubMed ID: 17384243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
    Agarwal S; Mathur M; Srivastava A; Ralhan R
    Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma.
    Bandoh N; Hayashi T; Kishibe K; Takahara M; Imada M; Nonaka S; Harabuchi Y
    Cancer; 2002 Apr; 94(7):1968-80. PubMed ID: 11932899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
    Kaur J; Srivastava A; Ralhan R
    Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy.
    Skirnisdóttir I; Seidal T; Gerdin E; Sorbe B
    Int J Gynecol Cancer; 2002; 12(3):265-76. PubMed ID: 12060448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of expression of p53 oncoprotein in oral carcinomas from India associated with betel and tobacco chewing.
    Kuttan NA; Rosin MP; Ambika K; Priddy RW; Bhakthan NM; Zhang L
    Eur J Cancer B Oral Oncol; 1995 May; 31B(3):169-73. PubMed ID: 7549756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers.
    Jane C; Nerurkar AV; Shirsat NV; Deshpande RB; Amrapurkar AD; Karjodkar FR
    J Oral Pathol Med; 2006 Nov; 35(10):595-601. PubMed ID: 17032391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological features of betel quid-related oral epithelial lesions in taiwan with special emphasis on the tumor progression and human papillomavirus association.
    Chang KC; Su IJ; Tsai ST; Shieh DB; Jin YT
    Oncology; 2002; 63(4):362-9. PubMed ID: 12417791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
    Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
    Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of apoptosis-regulating proteins p53, Bcl-2, and Bax in primary resected esophageal squamous cell carcinoma.
    Hsia JY; Chen CY; Hsu CP; Shai SE; Yang SS; Chuang CY; Wang PY; Chen JT
    Neoplasma; 2001; 48(6):483-8. PubMed ID: 11949842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p53 in oral squamous cell carcinoma and its association with risk habits in southern Thailand.
    Kerdpon D; Sriplung H; Kietthubthew S
    Oral Oncol; 2001 Oct; 37(7):553-7. PubMed ID: 11564575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of Bak expression in oral tongue squamous cell carcinomas.
    Xie X; Clausen OP; Boysen M
    Oncol Rep; 2003; 10(2):369-74. PubMed ID: 12579274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
    de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
    Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53, bcl-2, and bax as predictors of response to radiotherapy in esophageal cancer.
    Shimoji H; Miyazato H; Nakachi A; Kuniyoshi S; Isa T; Shiraishi M; Muto Y; Toda T
    Dis Esophagus; 2000; 13(3):185-90. PubMed ID: 11206630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.